Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry

• Hauptverfasser: Lieneke F.M. Ariëns (Verfasst von), Daphne S. Bakker (Verfasst von), Lotte S. Spekhorst (Verfasst von), Jorien van der Schaft (Verfasst von), Judith L. Thijs (Verfasst von), Inge Haeck (Verfasst von), Annebeth E. Flinterman (Verfasst von), Marijke Kamsteeg (Verfasst von), Marie L.A. Schuttelaar (Verfasst von), Marjolein S. De Bruin-Weller (Verfasst von)
• Format: Buch
• Veröffentlicht: Medical Journals Sweden, 2021-10-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Dupilumab treatment improves signs, symptoms, and quality of life in patients with moderate-to-severe atopic dermatitis. This study evaluated the impact of dupilumab treatment on absenteeism, presenteeism, and related costs in a large multi-centre cohort of adult patients with difficult-to-treat ato...